Alterations in excitation-contraction coupling in chronically ischemic or hibernating myocardium

Experimental and Clinical Cardiology

Volumn 10, Issue 3, 2005, Pages 142-145

  Bito, Virginie ^a   Heinzel, Frank R ^a   Claus, Piet ^b   Bijnens, Bart ^b   Verbeken, Erik ^b   Van der Velden, Jolanda ^c   Stienen, Ger ^c   Sipido, Karin R ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Calcium; Cardiac myocytes; Ischemic heart disease

Indexed keywords

CALCIUM CHANNEL L TYPE;

ADAPTATION; ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CALCIUM TRANSPORT; CELL ISOLATION; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; ELECTROSTIMULATION; EXCITATION CONTRACTION COUPLING; HEART DEPOLARIZATION; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE POTENTIAL; HEART MUSCLE REVASCULARIZATION; ISCHEMIC HEART DISEASE; MUSCLE FIBER CONTRACTION; MYOCARDIAL HIBERNATION; MYOFILAMENT; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; SWINE; WHOLE CELL;

EID: 24144470773     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. McMurray J, Pfeffer MA. New therapeutic options in congestive heart failure: Part II. Circulation 2002;105:2223-8.
2. McMurray J, Pfeffer MA. New therapeutic options in congestive heart failure: Part I. Circulation 2003;105:2099-106.
3. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985;72:V123-35.
4. Camici PG, Wijns W, Borgers M, et al. Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation 1997;96:3205-14.
5. Vanoverschelde JL, Wijns W, Borgers M, et al. Chronic myocardial hibernation in humans. From bedside to bench. Circulation 1997;95:1961-71.
6. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:211-21.
7. Cleland JG, Pennell DJ, Ray SG, et al; Carvedilol hibernating reversible ischaemia trial: Marker of success investigators. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): Randomised controlled trial. Lancet 2003;362:14-21.
8. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis. J Am Coll Cardiol 2002;39:1151-8.
9. Di Carli MF, Maddahi J, Rokhsar S, et al. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: Implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg 1998;116:997-1004.
10. Chen C, Chen L, Fallon JT, et al. Functional and structural alterations with 24-hour myocardial hibernation and recovery after reperfusion. A pig model of myocardial hibernation. Circulation 1996;94:507-16.
11. Fallavollita JA, Perry BJ, Canty JM Jr. 18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium. Circulation 1997;95:1900-9.
12. Canty JM Jr, Fallavollita JA. Resting myocardial flow in hibernating myocardium: Validating animal models of human pathophysiology. Am J Physiol 1999;277:H417-22.
13. Shivalkar B, Flameng W, Szilard M, Pislaru S, Borgers M, Vanhaecke J. Repeated stunning precedes myocardial hibernation in progressive multiple coronary artery obstruction. J Am Coll Cardiol 1999;34:2126-36.
14. Schulz R, Post H, Neumann T, Gres P, Luss H, Heusch G. Progressive loss of perfusion-contraction matching during sustained moderate ischemia in pigs. Am J Physiol Heart Circ Physiol 2001;280:H1945-53.
15. Heusch G. Hibernating myocardium. Physiol Rev 1998;78:1055-85.
16. Camici PG, Rimoldi OE. Myocardial blood flow in patients with hibernating myocardium. Cardiovasc Res 2003;57:302-11.
17. Elsasser A, Schlepper M, Klovekorn WP, et al. Hibernating myocardium: An incomplete adaptation to ischemia. Circulation 1997;96:2920-31.
18. Kloner RA, Bolli R, Marban E, Reinlib L, Braunwald E. Medical and cellular implications of stunning, hibernation, and preconditioning: An NHLBI Workshop. Circulation 1998;97:1848-67.
19. Maes A, Flameng W, Nuyts J, et al. Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation 1994;90:735-45.
20. Schwarz ER, Schaper J, vom DJ, et al. Myocyte degeneration and cell death in hibernating human myocardium. J Am Coll Cardiol 1996;27:1577-85.
21. Fallavollita JA, Jacob S, Young RF, Canty JM Jr. Regional alterations in SR Ca(2+)-ATPase, phospholamban, and HSP-70 expression in chronic hibernating myocardium. Am J Physiol 1999;277:H1418-28.
22. Heusch G, Rose J, Skyschally A, Post H, Schulz R. Calcium responsiveness in regional myocardial short-term hibernation and stunning in the in situ porcine heart. Inotropic responses to postextrasystolic potentiation and intracoronary calcium. Circulation 1996;93:1556-66.
23. Szilard M, Mesotten L, Maes A, et al. A nonsurgical porcine model of left ventricular dysfunction. Validation of myocardial viability using dobutamine stress echocardiography and positron emission tomography. Int J Cardiovasc Intervent 2000;3:111-20.
24. Weidemann F, Dommke C, Bijnens B, et al. Defining the transmurality of a chronic myocardial infarction by ultrasonic strain-rate imaging: Implications for identifying intramural viability: An experimental study. Circulation 2003;107:883-8.
25. Bito V, Heinzel FR, Weidemann F, et al. Cellular mechanisms of contractile dysfunction in hibernating myocardium. Circ Res 2004;94:794-801. (Erratum in 2004;94:e117).
26. Chen C, Li L, Chen LL, et al. Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses. Circulation 1995;92:756-66.
27. van der Velden J, Klein LJ, van der Bijl M, et al. Force production in mechanically isolated cardiac myocytes from human ventricular muscle tissue. Cardiovasc Res 1998;38:414-23.
28. Bito V, van der Velden J, Claus F, Bijnens B, Stienen GJ, Sipido KR. Maximal force development, but not myofilament calcium sensitivity, is reduced in myocytes from chronically ischemic, or hibernating, pig myocardium. Biophys J 2005;89:125A. (Abst)
29. Gao WD, Atar D, Liu Y, Perez NG, Murphy AM, Marban E. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res 1997;80:393-9.
30. Kim SJ, Kudej RK, Yatani A, et al. A novel mechanism for myocardial stunning involving impaired Ca(2+) handling. Circ Res 2001;89:831-7.
31. 2+ release in human failing cardiomyocytes. Cardiovasc Res 2004;62:63-73.
32. Gomez AM, Valdivia HH, Cheng H, et al. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 1997;276:800-6.
33. O'Rourke B, Kass DA, Tomaselli GF, Kaab S, Tunin R, Marban E. Mechanisms of altered excitation-contraction coupling in canine tachycardiainduced heart failure, I: Experimental studies. Circ Res 1999;84:562-70.
34. 2+ exchanger in failing pig myocytes. Circ Res 2003;92:897-903.
35. Canty JM Jr, Suzuki G, Banas MD, Verheyen F, Borgers M, Fallavollita JA. Hibernating myocardium: Chronically adapted to ischemia but vulnerable to sudden death. Circ Res 2004;94:1142-9.